Receptor activator of NF-kappa B ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infection. [electronic resource]
Producer: 20070807Description: 266-74 p. digitalISSN:- 0022-1767
- Animals
- Bone Resorption -- immunology
- Diphosphonates -- administration & dosage
- Disease Models, Animal
- Dose-Response Relationship, Immunologic
- Female
- Hydroxycholecalciferols -- toxicity
- Hypercalcemia -- immunology
- Imidazoles -- administration & dosage
- Immunity, Innate
- Immunoglobulin G -- administration & dosage
- Influenza A Virus, H3N2 Subtype -- immunology
- Longitudinal Studies
- Male
- Mice
- Mice, Inbred C57BL
- Orthomyxoviridae Infections -- immunology
- Osteoprotegerin -- administration & dosage
- RANK Ligand -- antagonists & inhibitors
- Receptor Activator of Nuclear Factor-kappa B -- antagonists & inhibitors
- Recombinant Fusion Proteins -- administration & dosage
- Zoledronic Acid
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.